(Q29620673)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

1 reference

1 reference

1 reference

Seeff LB

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

November 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

volume

36

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

issue

5 Suppl 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

page(s)

S35-46

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

Why is there such difficulty in defining the natural history of hepatitis C?

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Hepatitis C in asymptomatic blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Prognosis of chronic hepatitis C: results of a large, prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The impact of diagnosis of hepatitis C virus on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Modeling the hepatitis C virus epidemic in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Hepatitis C infection in African Americans: its natural history and histological progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Iron and chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Diabetes increases the risk of acute hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Treatment of hepatitis C patients with normal aminotransferases levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Impact of alcohol on the histological and clinical progression of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Hepatitis B and C virus serologies among Japanese Americans with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36806

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36806

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

30 April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12407575

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017